Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.
about
Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectivePaclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafishPaclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatmentMitotoxicity in distal symmetrical sensory peripheral neuropathiesPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patientsFunctional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.Current challenges in translational pain research.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response.Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn.Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic painPathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic painEffects of Taxol on Regeneration in a Rat Sciatic Nerve Transection ModelAxonal degeneration as a therapeutic target in the CNS.Mechanisms of distal axonal degeneration in peripheral neuropathies.Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse.Nicotine prevents and reverses paclitaxel-induced mechanical allodynia in a mouse model of CIPN.TrpA1 activation in peripheral sensory neurons underlies the ionic basis of pain hypersensitivity in response to vinca alkaloids.Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects.HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial.Effect of certain trimethoxy flavones on paclitaxel - induced peripheral neuropathy in mice.Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy.
P2860
Q26777967-14827D20-B8B6-4F3E-8802-1A62AAC0285DQ27316580-6827ADF7-0E20-428A-9DD0-5C101D47A4BEQ28073057-9FA91D0B-F550-4ADE-80DC-27E845F098DEQ28834071-5B435E94-A805-44DF-A5D8-CFAFC102E4B1Q33744706-F27AF547-400B-4D7D-A0EF-603C3B6489C1Q34562783-DD195632-E143-4A87-901B-42219F31E23EQ35449249-130ED836-2B6F-47DC-8622-4AB6797DF760Q35613627-E9EC84B3-3AD4-439F-8E29-EE4A4E8D8045Q35740234-15CEBB32-92F8-448B-A95C-9ECD3E09019EQ35784775-D8C90796-D15E-412E-BF28-8784D0E3EAB4Q36350737-BB63FB06-1A79-46A4-AFF8-D5C2D15DCE47Q36439933-A313C9E5-0DAD-4B26-A4F0-93713FAF65ECQ36847553-E106396D-C71F-4C6A-ABA1-50F03FBD124EQ36963585-18762C6E-3EC5-418C-9DCA-1EFF98556C0CQ37114802-6280ABFF-3B87-4E6D-B688-ECB99409488DQ37117256-377968B2-3548-45F6-A2DE-2694557151A4Q37399781-03D155C7-3A7A-44BA-AB45-4E6A5FB234F7Q37625422-19DD7244-0EDF-4630-9FE1-B23F4F00EFBFQ37633265-29F24EF0-08A4-4DD1-AFC6-8A221B6DFB9FQ37990880-1E987F1A-2A51-42FA-A3DF-E01EC9DCEC8BQ38330759-1D679E5C-51DA-4132-B0D9-112886AFD0A7Q39178503-FE30E46A-BA19-4082-91CE-5A2AD8AFD3B2Q39283600-2BCA8AA2-D136-4DA6-9672-A47327CFFDB5Q45053532-1D4A87E4-0C66-4CD8-843C-F9A1987F57FBQ45070329-0C285FB9-BBED-4B77-A16A-00F4A8FD4907Q45989783-CE2F0D12-0D5F-4025-BA0C-0DA795078673Q47151258-5C69CF26-A8CC-4AF3-902B-E3610D0F11C5Q48656158-529C1309-4D48-4F54-83A2-A5646810282CQ50858728-7023EE77-6D24-4945-BB01-24536D13ADE9Q51129031-DAF6EFE9-04CD-4D13-8F2A-920872F6502EQ55375369-2F6F5E58-ED78-4CE6-8765-8A90F87A392BQ55430090-E014DF91-C689-4625-8F40-629CAA5A944BQ55455320-55892C91-3FC5-4472-BB80-236E61C2A3C4
P2860
Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@ast
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@en
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@nl
type
label
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@ast
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@en
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@nl
prefLabel
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@ast
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@en
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@nl
P2093
P2860
P1476
Terminal arbor degeneration--a ...... tineoplastic agent paclitaxel.
@en
P2093
Chiang Siau
Gary J Bennett
Wen H Xiao
P2860
P304
P356
10.1111/J.1460-9568.2011.07652.X
P407
P577
2011-03-13T00:00:00Z